Eli Lilly and Company announces new initiatives to help COVID-19 patients in India as part of its commitment to bring the full force of its scientific and medical expertise to attack the coronavirus pandemic around the world. Lilly is offering donations of baricitinib to the Indian government through Direct Relief while simultaneously working with local Indian pharmaceutical companies to execute royalty-free voluntary licensing agreements to accelerate the manufacturing and distribution of the medicine in India during the pandemic.
- Read more about Lilly accelerating baricitinibs availability in India
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/lilly-accelerating-baricitinibs-availability-in-india
No comments:
Post a Comment